Chair and Clinical Department of General, Colorectal and Trauma Surgery. School of Health Sciences of the Silesian Medical University in Katowice. Saint’s Barbara memorial Main District Hospital in Sosnowiec. Trauma Centre
Chair and Clinical Department of General, Colorectal and Trauma Surgery. School of Health Sciences of the Silesian Medical University in Katowice. Saint’s Barbara memorial Main District Hospital in Sosnowiec. Trauma Centre
Chair and Clinical Department of General, Colorectal and Trauma Surgery. School of Health Sciences of the Silesian Medical University in Katowice. Saint’s Barbara memorial Main District Hospital in Sosnowiec. Trauma Centre
Chair and Clinical Department of General, Colorectal and Trauma Surgery. School of Health Sciences of the Silesian Medical University in Katowice. Saint’s Barbara memorial Main District Hospital in Sosnowiec. Trauma Centre
Department of Molecular Biology. School of Pharmacy with Division of Medical Analytics in Sosnowiec of the Silesian Medical University in Katowice
References
1. Paschos KA , Canovas D, Bird NC : The role of cell adhesion molecules in the progression of colorectal cancer and the development of liver metastasis. Cell Signal 2009; 21(5): 665-74.[WoS][Crossref][PubMed]
2. Mantur M, Wojszel J: Cząsteczki adhezyjne oraz ich udział w procesie zapalnym i nowotworowym. Pol Merk Lek 2008; 24(140): 177-80.
3. Li DM , Feng YM : Signaling mechanism of cell adhesion molecules in breast cancer metastasis: potential therapeutic targets. Breast Cancer Res Treat 2011; 128(1): 7-21.[PubMed][Crossref][WoS]
4. Boscacci RT, Pfeiffer F, Gollmer K et al.: Comprehensive analysis of lymph node stroma-expressed Ig superfamily members reveals redundant and nonredundant roles for ICAM-1, ICAM-2, and VCAM-1 in lymphocyte homing. Blood 2010; 116(6): 915-25.[WoS][Crossref][PubMed]
5. Brooks SA , Lomax-Browne HJ, Carter TM et al.: Molecular interactions in cancer cell metastasis. Acta Histochem 2010; 112(1): 3-25.[Crossref][PubMed]
6. Lawson C, Wolf S: ICAM-1 signaling in endothelial cells. Pharmacol Rep 2009; 61(1): 22-32.[Crossref][PubMed]
7. Usami Y, Ishida K, Sato S et al.: Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage/ cancer cell adhesion. Int J Cancer 2013; 133(3): 568-78.[PubMed][Crossref]
8. Cook-Mills JM , Marchese ME, Abdala-Valencia H: Vascular Cell Adhesion Molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal 2011; 15(6): 1607-38.[WoS][Crossref]
9. Ahmed MM , Mohammed SH: Significance of intratumoral microvessel density quantification based on immunohistochemical detection of PECAM-1 and vWF in colorectal carcinoma from Iraqi patients. Indian J Pathol Microbiol 2010; 53(3): 439-46.[WoS][PubMed][Crossref]
10. Alevizos L, Gomatos IP, Smparounis S et al.: Review of the molecular profile and modern prognostic markers for gastric lymphoma: How do they affect clinical practice? Can J Surg 2012; 55(2): 117-24.[PubMed][WoS]
11. K obayashi M, Hoshino H, Suzawa K et al.: Two distinct lymphocyte homing systems involved in the pathogenesis of chronic inflammatory gastrointestinal diseases. Semin Immunopathol 2012; 34(3): 401-13.[WoS]
12. Suzuki A, Kobayashi M, Matsuda K: Induction of high endothelial venule-like vessels expressing GlcNAc6ST-1-mediated L-selectin ligand carbohydrate and mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in a mouse model of „Candidatus Helicobacter heilmannii”-induced gastritis and gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Helicobacter 2010; 15(6): 538-48.[WoS]
13. Thomas S, Baumgart DC : Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis. Inflammopharmacology 2012; 20(1): 1-18.[Crossref][PubMed]
14. van der Voort van Zijp J, Hoekstra HJ, Basson MD : Evolving management of colorectal cancer. World J Gastroenterol 2008; 14(25): 3956-67.[PubMed][WoS]
15. Weller M, Stupp R, Hegi M et al.: Individualized targeted therapy for glioblastoma: fact or fiction? Cancer J 2012; 18(1): 40-44.[PubMed][Crossref]
16. Sun W: Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy. J Hematol Oncol 2012; 5: 63.[Crossref][PubMed][WoS]
18. L ouderbough JM , Schroeder JA : Understanding the dual nature of CD44 in breast cancer progression. Mol Cancer Res 2011; 9(12): 1573-86.[WoS]
19. Imrich S, Hachmeister M, Gires O: EpCAM and its potential role in tumor-initiating cells. Cell Adh Migr 2012; 6(1): 30-38.[Crossref][WoS][PubMed]
20. Korja M, Jokilammi A, Salmi TT et al.: Absence of polysialylated NCAM is an unfavorable prognostic phenotype for advanced stage neuroblastoma. BMC Cancer 2009; 9: 57.[PubMed][WoS][Crossref]
21. Kulahin N, Walmod PS: The neural cell adhesion molecule NCAM2/OCAM/RNCAM, a close relative to NCAM. Adv Exp Med Biol 2010; 663: 403-20.
22. Tsanou E, Peschos D, Batistatou A et al.: The E-Cadherin Adhesion Molecule and Colorectal Cancer. A Global Literature Approach. Anticancer Res 2008; 28(6A): 3815-26.[PubMed]
23. Paredes J, Correia AL , Ribeiro AS et al.: Pcadherin expression in breast cancer: a review. Breast Cancer Res 2007; 9(5): 214.[Crossref]
24. Hibi K, Goto T, Mizukami H et al.: Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer. Anticancer Res 2009; 29(6): 2215-17.
25. Yoshioka H, Yamamoto S, Hanaoka H et al.: In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy. Cancer Immunol Immunother 2012; 61(8): 1211-20.[Crossref][WoS]